Pancreatic Cancer Research

ResearcherXuzhou Medical CollegeNo recent work listed

Xin Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8178-4737; OpenAlex author ID A5100687934. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper

Papers 8

  1. MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. Co-author DOI 10.1155/2022/5514715↗
  2. MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer. Co-author PMID 34522457↗
  3. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. Co-author DOI 10.1016/j.ejphar.2020.173225↗
  4. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1042/bsr20200214↗
  5. Exploring and validating the clinical risk factors for pancreatic cancer in chronic pancreatitis patients using electronic medical records datasets: three coho… Co-author DOI 10.21037/tcr.2019.11.49↗
  6. Downregulation of long noncoding RNA SNHG1 inhibits cell proliferation, metastasis, and invasion by suppressing the Notch-1 signaling pathway in pancreatic can… Co-author DOI 10.1002/jcb.27897↗
  7. The autophagy-related genes Beclin1 and LC3 in the prognosis of pancreatic cancer. Co-author PMID 31934136↗
  8. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognost… Last author DOI 10.1159/000493033↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ren Lang · 6 shared papers, 2018–2022 · strength 0.71
  2. Qiang He · 3 shared papers, 2020–2022 · strength 0.37
  3. Zhangyong Ren · 3 shared papers, 2020–2022 · strength 0.37
  4. Xinxue Zhang · 2 shared papers, 2021–2022 · strength 0.28
  5. Qiang He · 2 shared papers, 2018–2021 · strength 0.22
  6. Zhe Liu · 2 shared papers, 2020 · strength 0.22
  7. Long Cui · 2 shared papers, 2019 · strength 0.20
  8. Junming Xu · 1 shared paper, 2022 · strength 0.15
  9. Qing Chen · 1 shared paper, 2022 · strength 0.15
  10. Zhe Liu · 1 shared paper, 2022 · strength 0.15
  11. Zhigang Zhang · 1 shared paper, 2020 · strength 0.13
  12. Xiaobo Zhou · 1 shared paper, 2020 · strength 0.13
  13. Shaocheng Lyu · 1 shared paper, 2020 · strength 0.11
  14. Xinhui Zhang · 1 shared paper, 2019 · strength 0.10
  15. Xinhui Zhang · 1 shared paper, 2019 · strength 0.10
  16. Zhigang Zhang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.